About Us

At Therapure Biopharma Inc. we’re specialists in biologics therapeutics, and we act on a passion for enhancing patient care through our three divisions: Therapure Biomanufacturing, Therapure Innovations and Therapure Biologics.

Where We Started

We were established as a contract development and manufacturing organization (CDMO) in 2008 through the vision of The Catalyst Capital Group Inc. (Catalyst), a Canadian-based private equity manager. Catalyst continues to support our growth through substantial investment in facility upgrades, capacity expansion and new technologies. This promotes the advancement of our pipeline and evolving new divisions, as well as allowing us to meet Therapure’s growing biomanufacturing demand.

Therapure Biopharma Inc. Today

We have established three distinct divisions with a unifying commitment to quality and patient safety that underpins everything we do.

Therapure Biomanufacturing — an award-winning division focused on contract development and manufacturing of complex biologics. With a passion for enhancing the client experience, we strive to exceed expectations throughout each project. If you would like to learn more about our contract services, including biologic process development, cGMP biomanufacturing and/or aseptic fill/finish, please click here.

Therapure Innovations — an in-house, proprietary-drug development division. We apply scientific expertise to advancing the treatment of diseases using proprietary protein technologies. If you would like to learn more about how we apply our platform technologies to the following areas of research: liver cancer, hepatitis C and anemia, please click here.

Therapure Biologics — a division focused on using our proprietary PlasmaCap EBA™ technology to develop a portfolio of plasma-derived pharmaceutical products. This division is supported by our biomanufacturing capability and plasma protein expertise. If you would like to learn more, please click here.

Therapure Corporate Values

Excellence—We strive to exceed our own expectations as well as those of our clients, partners, investors and regulators. We will maintain our skills, knowledge, know-how, processes, quality systems and capital assets at an industry-leading level.

Trust—We recognize that our stakeholders’ trust is our most valuable asset. The desire to earn and maintain their trust guides our actions at all times. We view ourselves as an extension of their organizations.

Transparency— We communicate openly with internal and external stakeholders. We encourage openness throughout the organization.

Team work—We understand that a team is stronger than the individual members: we succeed together. We each play a role in Therapure’s success.

Accountability—We accept responsibility for our decisions and performance. We must deliver on our promises.